← Evidence map

ArticleClinical and molecular hepatology2026

Bacteroides eggerthii ameliorates metabolic dysfunction-associated steatotic liver disease through host-microbe signaling and highlights 2-hydroxyisocaproate as a potential effector.

Jiyi Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41146521